MedPath

A study to find out whether vitrectomy is better than laser for diabetic patients with partial bleeding into the vitreous jelly.

Phase 2
Completed
Conditions
Health Condition 1: null- Proliferative diabetic retinopathy with localized vitreous hemorrhage. Randomized controlled trial.Health Condition 2: E103- Type 1 diabetes mellitus with ophthalmic complications
Registration Number
CTRI/2010/091/003022
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Inclusion criteria

PDR + localized vitreous hemorrhage allowing visualization of >2/3rd of the fundus + with no pre-existing tractional RD

Exclusion Criteria

Exclusion criteria
1.One- eyed
2. Other concomitant eye disease likely to affect ? glaucoma, corneal opacity.
3. Patient on dialysis
4. Patient not willing to participate
5. Patients who have received an injection of anti-VEGF within the past 60 days prior to enrollment.
Inclusion and exclusion criteria for participant selection, including age and sex.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main outcome variables 1. Vision. Vision to be evaluated on LOGMAR chart and contrast sensitivity on Pelli Robson chart at every visitTimepoint: No timepoints
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath